Sort
261,768 grants matching “gene therapy”
Notch-Mediated Expansion of Cord Blood Progenitors for Stem Cell Transplant
$2,484,046Colleen Delaney · Fred Hutchinson Cancer Research Center · P50 · FY2014 · HL
Epidemiology and Natural History of Cancer-Associated Viruses
$2,483,980Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
THE THERAPY OF AML
$2,483,417Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA
Developing functional and authenticated RPE tissue from iPS cells
$2,482,712Kapil Bharti · National Eye Institute · ZIA · FY2023 · EY
CALIFORNIA TEACHERS STUDY
$2,482,687Leslie Bernstein · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,482,574Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2019 · CA
Studies of Ocular inflammation: Clinical & Translational Research
$2,482,189Shilpa Kodati · National Eye Institute · ZIA · FY2021 · EY
Functional consequences of stem and progenitor cell heterogeneity
$2,482,031David T Scadden · Massachusetts General Hospital · P01 · FY2025 · HL
Disease mechanism and therapies for retinal degeneration
$2,481,462Tiansen Li · National Eye Institute · ZIA · FY2024 · EY
Functional consequences of stem and progenitor cell heterogeneity
$2,481,366David T Scadden · Massachusetts General Hospital · P01 · FY2017 · HL
Gene therapy for disorders of the extracellular matrix
$2,481,348Douglas Gould · University Of California, San Francisco · RF1 · FY2023 · NS
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
$2,480,996Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2023 · HL
SPORE in Lung Cancer
$2,480,919Vanderbilt University · P50 · FY2002 · CA
Mammalian Developmental Genetics and Stem Cells
$2,480,280Heiner Westphal · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
$2,480,272Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2022 · HL
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,480,144Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Pathway Analysis in Tuberculosis
$2,480,141Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI
Ecopathogenomics of sexually transmitted infections (EPSTI)
$2,479,885Patrik M Bavoil · University Of Maryland Baltimore · U19 · FY2014 · AI
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,479,625Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
OTHER FUNCTIONS SBIR PHASE II TOPIC 275, GENERIC ERBITUX FOR TREATMENT OF EGFR+
$2,479,561Peisheng Hu · Cancer Therapeutics Laboratories, Inc. · N44 · FY2012 · CA
ETIB Clinical Trials
$2,479,411Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
$2,479,201Robert A Britton · Baylor College Of Medicine · U19 · FY2025 · AI
Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor
$2,478,864Lei Shi · National Institute On Drug Abuse · ZIA · FY2023 · DA
SPORE IN BREAST CANCER
$2,478,775University Of Alabama At Birmingham · P50 · FY2000 · CA
Extending the Phenotype of Nonsyndromic Orofacial Clefting
$2,478,699Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · DE